RMC
BMY icon

Resources Management Corp’s Bristol-Myers Squibb BMY Stock Holding History

Resources Management Corp’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.67M Sell
27,575
-225
-0.8% -$13.1K 0.22% 92
2025
Q4 		$1.5M Hold
27,800
– – 0.19% 94
2025
Q3 		$1.25M Sell
27,800
-4,110
-13% -$192K 0.16% 104
2025
Q2 		$1.48M Sell
31,910
-2,763
-8% -$136K 0.2% 94
2025
Q1 		$2.12M Sell
34,673
-3,562
-9% -$208K 0.3% 75
2024
Q4 		$2.16M Sell
38,235
-15,472
-29% -$864K 0.3% 75
2024
Q3 		$2.78M Sell
53,707
-3,115
-5% -$146K 0.37% 64
2024
Q2 		$2.36M Sell
56,822
-2,260
-4% -$101K 0.34% 67
2024
Q1 		$3.2M Sell
59,082
-4,389
-7% -$224K 0.47% 56
2023
Q4 		$3.26M Sell
63,471
-4,150
-6% -$218K 0.48% 51
2023
Q3 		$3.92M Sell
67,621
-520
-0.8% -$31.9K 0.64% 45
2023
Q2 		$4.36M Buy
68,141
+62,179
+1,043% +$4.17M 0.68% 40
2023
Q1 		$115K Sell
5,962
-63,039
-91% -$4.45M 0.02% 246
2022
Q4 		$4.96M Sell
69,001
-15
-0% -$1.13K 0.78% 35
2022
Q3 		$4.91M Sell
69,016
-515
-0.7% -$37.4K 0.85% 32
2022
Q2 		$5.35M Sell
69,531
-467
-0.7% -$35.6K 0.87% 30
2022
Q1 		$5.11M Sell
69,998
-7,345
-9% -$493K 0.71% 37
2021
Q4 		$4.82M Sell
77,343
-8,869
-10% -$520K 0.63% 40
2021
Q3 		$5.1M Sell
86,212
-2,034
-2% -$134K 0.73% 35
2021
Q2 		$5.9M Sell
88,246
-4,611
-5% -$301K 0.83% 33
2021
Q1 		$5.86M Sell
92,857
-3,073
-3% -$191K 0.89% 32
2020
Q4 		$5.95M Sell
95,930
-3,219
-3% -$198K 0.96% 28
2020
Q3 		$5.98M Buy
99,149
+41
+0% +$2.47K 1.08% 24
2020
Q2 		$5.83M Buy
99,108
+1,970
+2% +$118K 1.11% 24
2020
Q1 		$5.41M Sell
97,138
-3,605
-4% -$220K 1.21% 24
2019
Q4 		$6.47M Buy
100,743
+35,885
+55% +$2.06M 1.12% 27
2019
Q3 		$3.29M Buy
+64,858
New +$3.05M 0.61% 44
2018
Q4 		$3.45M Sell
66,419
-4,454
-6% -$239K 0.77% 39
2018
Q3 		$4.4M Buy
+70,873
New +$4.21M 0.8% 40

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Resources Management Corp's BMY Position: Q1 2026 in Review

Resources Management Corp reduced its Bristol-Myers Squibb (BMY) stake by 0.81% in Q1 2026, selling an estimated $13.1K and leaving 27,575 shares worth $1.67M. The position accounts for 0.22% of the portfolio, ranked #92.

Resources Management Corp first reported a position in BMY in Q3 2018 and has held it in 29 quarters since. The position peaked at $6.47M in Q4 2019. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Resources Management Corp held 27,575 shares of Bristol-Myers Squibb worth $1.67M as of Q1 2026.
  • Resources Management Corp sold 225 Bristol-Myers Squibb shares in Q1 2026, an estimated $13.1K.
  • Bristol-Myers Squibb made up 0.22% of Resources Management Corp's portfolio in Q1 2026, its #92 holding.
  • Resources Management Corp first reported a position in Bristol-Myers Squibb in Q3 2018 and has held it in 29 quarters since.
  • Resources Management Corp's Bristol-Myers Squibb position peaked at $6.47M in Q4 2019.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Resources Management Corp's 13F filing for Q1 2026, filed 15 May 2026.